Grifols, Brookfield

Billionaire Grifols Family’s Woes in Focus After Brookfield Exit
For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical fortunes, Brookfield Asset Management’s plan to take its troubled eponymous company private had been a way to turn it around — far from the glare of markets.
Brookfield Set to Drop Grifols Bid as Family Shuns Others
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation. The Spanish company’s billionaire founding family said it won’t support any new bid to take its namesake drug-maker private.
Brookfield abandons the €6.5 billion takeover bid for Grifols, which plummets on the stock market
The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to disagreements over the price with the
Brookfield abandons plan for €6.45-billion takeover of drug maker Grifols
Brookfield withdrew its bid for the Spanish pharmaceutical company following a deadlock between the two side over price
Brookfield drops US$6.8-billion offer to buy drugmaker Grifols
Grifols shares fell as much as 14 per cent after the news was published by Bloomberg, the biggest intra-day decline since Feb. 29. They traded eight per cent lower at 3 p.m. in Madrid. Its bonds due in October 2028 recorded the steepest daily drop since January in early morning trading to around 89 cents.
Grifols shares sink after Brookfield walks away from €6.45bn offer
Brookfield’s decision to withdraw from talks after indicating last week that it could submit a €6.45bn bid for Grifols piles further pressure on the leading maker of medicines derived from blood plasma.
Grifols shares tumble after Brookfield drops takeover plan
Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over the pharmaceutical company's value, while Grifols said it concurred with the decision.
Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Citing unnamed sources, Bloomberg reported overnight that Brookfield is preparing to drop its 6.45 billion-euro ($6.77 billion) bid to acquire Grifols after failing to reach an agreement with its board on price.
Brookfield Is Said to Plan to Walk Away From Grifols Bid
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation for the Spanish drug maker, according to people familiar with the matter.
Grifols shares tumble after report on Brookfield abandoning takeover plan
Shares in Grifols were falling on Wednesday morning after Bloomberg reported Canadian fund Brookfield is considering dropping its plan to take over the Spanish pharmaceutical firm. The Canadian private equity firm is walking away on disagreement on the company's value,
Grifols drops as Brookfield is said to drop take-private bid
Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma therapeutics company private. Read more here.
Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols
Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over ...
pharmaphorum2h
Grifols slides as Brookfield pulls out of takeover talks
Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...
Grifols Board Announces Termination Of Discussions With Brookfield - Quick Facts
The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...
Brookfield abandona oferta de US$6.800 millones por farmacéutica Grifols
Brookfield Asset Management Ltd. abandonó los planes de adquirir Grifols SA, poniendo fin a meses de negociaciones para ...